loadpatents
name:-0.054662942886353
name:-0.032073020935059
name:-0.0059220790863037
Krawiec; Mariusz Patent Filings

Krawiec; Mariusz

Patent Applications and Registrations

Patent applications and USPTO patent grants for Krawiec; Mariusz.The latest application filed is for "solid forms of (r)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-- fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl)cyclopropanecarboxa- mide".

Company Profile
5.38.54
  • Krawiec; Mariusz - Marlborough MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide
Grant 11,291,662 - Hurter , et al. April 5, 2		2022-04-05
Solid Forms of (R)-1(2,2-Difluorobenzo[D][1,3]Dioxol-5-yl)-N-(1-(2,3-Dihydroxypropyl)-6-- Fluoro-2-(1-Hydroxy-2-Methylpropan-2-yl)-1H-Indol-5-yl)Cyclopropanecarboxa- mide
App 20210340128 - Keshavarz-Shokri; Ali ;   et al.		2021-11-04
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide
App 20210251978 - Hurter; Patricia ;   et al.		2021-08-19
Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-- fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxa- mide
Grant 10,906,891 - Keshavarz-Shokri , et al. February 2, 2		2021-02-02
Solid Forms Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-- Methylpyridin-2-yl) Benzoic Acid
App 20200377484 - Keshavarz-Shokri; Ali ;   et al.		2020-12-03
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide
App 20200352930 - Hurter; Patricia ;   et al.		2020-11-12
Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-- methylpyridin-2-yl) benzoic acid
Grant 10,597,384 - Keshavarz-Shokri , et al.		2020-03-24
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide
Grant 10,537,565 - Hurter , et al. Ja		2020-01-21
Solid Forms of (R)-1(2,2-Difluorobenzo[D][1,3]Dioxol-5-yl)-N-(1-(2,3-Dihydroxypropyl)-6-- Fluoro-2-(1-Hydroxy-2-Methylpropan-2-y
App 20190270728 - Keshavarz-Shokri; Ali ;   et al.		2019-09-05
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide
App 20190070162 - Hurter; Patricia ;   et al.		2019-03-07
Pharmaceutical Compositions And Administrations Thereof
App 20190038615 - Van Goor; Fredrick F. ;   et al.		2019-02-07
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-- fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxa- mide
Grant 10,081,621 - Keshavarz-Shokri , et al. September 25, 2		2018-09-25
Pharmaceutical Compositions And Administrations Thereof
App 20180153874 - Van Goor; Fredrick F. ;   et al.		2018-06-07
Solid Forms Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-- Methylpyridin-2-yl) Benzoic Acid
App 20180127398 - Keshavarz-Shokri; Ali ;   et al.		2018-05-10
Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-- 3-carboxamide
Grant 9,931,334 - Hurter , et al. April 3, 2		2018-04-03
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-- methylpyridin-2-yl) benzoic acid
Grant 9,840,499 - Keshavarz-Shokri , et al. December 12, 2		2017-12-12
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide
App 20170231970 - Hurter; Patricia ;   et al.		2017-08-17
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide
Grant 9,670,163 - Hurter , et al. June 6, 2		2017-06-06
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-- methylpyridin-2-yl) benzoic acid
Grant 9,434,717 - Keshavarz-Shokri , et al. September 6, 2		2016-09-06
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide
App 20160229806 - Hurter; Patricia ;   et al.		2016-08-11
Solid Forms Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-- Methylpyridin-2-yl) Benzoic Acid
App 20160221995 - Keshavarz-Shokri; Ali ;   et al.		2016-08-04
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-- methylpyridin-2-yl)benzoic acid
Grant 9,314,455 - Keshavarz-Shokri , et al. April 19, 2		2016-04-19
Pharmaceutical Compositions And Administrations Thereof
App 20160067239 - Van Goor; Fredrick F. ;   et al.		2016-03-10
Solid Forms Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-- Methylpyridin-2-yl) Benzoic Acid
App 20160052916 - Keshavarz-Shokri; Ali ;   et al.		2016-02-25
Pharmaceutical Compositions and Administrations Thereof
App 20160022665 - Van Goor; Fredrick F. ;   et al.		2016-01-28
Pharmaceutical Compositions and Administrations Thereof
App 20160022664 - Van Goor; Fredrick F. ;   et al.		2016-01-28
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-- methylpyridin-2-yl) benzoic acid
Grant 9,150,552 - Keshavarz-Shokri , et al. October 6, 2		2015-10-06
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide
Grant 9,139,530 - Hurter , et al. September 22, 2		2015-09-22
Solid Forms of (R)-1(2,2-Difluorobenzo[D][1,3]Dioxol-5-yl)-N-(1-(2,3-Dihydroxypropyl)-6-- Fluoro-2-(1-Hydroxy-2-Methylpropan-2-yl)-1H-Indol-5-yl)Cyclopropanecarboxa- mide
App 20150203478 - Keshavarz-Shokri; Ali ;   et al.		2015-07-23
Solid Forms of 3-(6-(1-(2,2-Difluorobenzo[D][1,3]Dioxol-5-yl)Cyclopropanecarboxamido)-3-- Methylpyridin-2-yl)Benzoic Acid
App 20150196539 - Keshavarz-Shokri; Ali ;   et al.		2015-07-16
Pharmaceutical Compositions and Administrations Thereof
App 20150164881 - Van Goor; Fredrick F. ;   et al.		2015-06-18
Pharmaceutical Compositions And Administrations Thereof
App 20150164883 - Van Goor; Fredrick F. ;   et al.		2015-06-18
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-YL)-N-(1-(2,3-dihydroxypropyl-6-f- luoro-2-(1-hydroxy-2-methylpropan-2-YL)-1H-indol-5-YL)-cyclopropanecarboxa- mide
Grant 9,051,303 - Keshavarz-Shokri , et al. June 9, 2		2015-06-09
Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pryimidin-5-yl]-7-- (tetrahydrofuran-2-yl)-1H-benzimidazol-2-yl]urea
Grant 9,040,542 - Shannon , et al. May 26, 2		2015-05-26
Pharmaceutical Compositions And Administrations Thereof
App 20150141459 - Van Goor; Fredrick F. ;   et al.		2015-05-21
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-- methylpyridin-2-yl)benzoic acid
Grant 8,969,574 - Keshavarz-Shokri , et al. March 3, 2		2015-03-03
Solid Forms of (R)-1(2,2-Difluorobenzo[D][1,3]Dioxol-5-yl)-N-(1-(2,3-Dihydroxypropyl-6-F- luoro-2-(1-Hydroxy-2-Methylpropan-2-yl)-1H-lndol-5-yl)-Cyclopropanecarboxa- mide
App 20150005344 - Keshavarz-Shokri; Ali ;   et al.		2015-01-01
Solid Forms Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-- Methylpyridin-2-yl) Benzoic Acid
App 20140371275 - Keshavarz-Shokri; Ali ;   et al.		2014-12-18
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide
App 20140329855 - Arekar; Sneha G. ;   et al.		2014-11-06
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxo1-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
Grant 8,846,718 - Keshavarz-Shokri , et al. September 30, 2		2014-09-30
Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide
App 20140242172 - Hurter; Patricia ;   et al.		2014-08-28
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-f- luoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxam- ide
Grant 8,802,868 - Keshavarz-Shokri , et al. August 12, 2		2014-08-12
Solid Forms of 3-(6-(1-(2,2-Difluorobenzo[D][1,3]Dioxol-5-yl)Cyclopropanecarboxamido)-3-- Methylpyridin-2-yl)Benzoic Acid
App 20140221430 - KESHAVARZ-SHOKRI; Ali ;   et al.		2014-08-07
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide
Grant 8,785,476 - Arekar , et al. July 22, 2		2014-07-22
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-- methylpyridin-2-yl)benzoic acid
Grant 8,742,122 - Keshavarz-Shokri , et al. June 3, 2		2014-06-03
Solid forms of N-(4-(7-azabicyclo[2.2,1]heptan-7-yl)-2-trifluoromethyl)phenyl)-4-oxo-5-(- trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide
Grant 8,741,922 - Zhang , et al. June 3, 2		2014-06-03
Solid Forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-- (trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide
App 20140113933 - Zhang; Beili ;   et al.		2014-04-24
Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
Grant 8,653,103 - Keshavarz-Shokri , et al. February 18, 2		2014-02-18
Solid Forms of 3-(6-(1-(2,2-Difluorobenzo[D][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-- methylpyridin-2-yl) Benzoic Acid
App 20140011846 - Keshavarz-Shokri; Ali ;   et al.		2014-01-09
Pharmaceutical Compositions And Administrations Thereof
App 20130338188 - Van Goor; Fredrick F. ;   et al.		2013-12-19
Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide
App 20130317060 - Hurter; Patricia ;   et al.		2013-11-28
Solid Forms Of Gyrase Inhibitor (r)-1-ethyl-3-[5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-yl]-7-(tetrahyd- Rofuran-2-yl]-1h-benzimidazol-2-yl]urea
App 20130317222 - Shannon; Dean ;   et al.		2013-11-28
Solid Forms of 3-(6-(1-(2,2-Difluorobenzo[D][1,3]Dioxol-5-yl)Cyclopropanecarboxamido)-3-- Methylpyridin-2-yl)Benzoic Acid
App 20130296379 - Keshavarz-Shokri; Ali ;   et al.		2013-11-07
Solid Forms Of Gyrase Inhibitor (r)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-yl]-7-- (tetrahydrofuran-2-yl)-1h-benzimidazol-2-yl]urea
App 20130267540 - Shannon; Dean ;   et al.		2013-10-10
Solid Forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5- -(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide
App 20130231368 - Zhang; Beili ;   et al.		2013-09-05
Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
Grant 8,507,687 - Keshavarz-Shokri , et al. August 13, 2		2013-08-13
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
Grant 8,507,534 - Keshavarz-Shokri , et al. August 13, 2		2013-08-13
Solid forms of gyrase inhibitor (R)-1-ethyl-3-[5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-YL]-7-(tetrahyd- rofuran-2-yl)-1H-benzimidazol-2-YL]urea
Grant 8,481,552 - Shannon , et al. July 9, 2		2013-07-09
Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-yl]-7-- (tetrahydrofuran-2-yl)-1H-benzimidazol-2-yl]urea
Grant 8,476,281 - Shannon , et al. July 2, 2		2013-07-02
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide
Grant 8,471,029 - Arekar , et al. June 25, 2		2013-06-25
Pharmaceutical Compositions And Administrations Thereof
App 20130158071 - Van Goor; Fredrick F. ;   et al.		2013-06-20
Pharmaceutical Compositions And Administrations Thereof
App 20130143919 - Van Goor; Fredrick F. ;   et al.		2013-06-06
Solid Forms of (R)-1(2,2-Difluorobenzo[D][1,3]Dioxol-5-yl)-N-(1-(2,3-Dihydroxypropyl-6-F- luoro-2-(1-Hydroxy-2-Methylpropan-2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxa- mide
App 20130143918 - Keshavarz-Shokri; Ali ;   et al.		2013-06-06
Solid Forms Of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-trifluoromethyl)phenyl)-4-oxo-5-(- Trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide
App 20130137722 - Zhang; Beili ;   et al.		2013-05-30
Pharmaceutical Compositions And Administrations Thereof
App 20130131107 - Van Goor; Fredrick F. ;   et al.		2013-05-23
Solid forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5- -(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide
Grant 8,436,014 - Zhang , et al. May 7, 2		2013-05-07
Solid Forms Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic Acid
App 20130085158 - KESHAVARZ-SHOKRI; ALI ;   et al.		2013-04-04
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide
Grant 8,410,274 - Hurter , et al. April 2, 2		2013-04-02
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide
App 20130079367 - Arekar; Sneha G. ;   et al.		2013-03-28
Solid forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(- Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide
Grant 8,389,727 - Zhang , et al. March 5, 2		2013-03-05
Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide
App 20130018071 - Arekar; Sneha G. ;   et al.		2013-01-17
Solid Forms Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic Acid
App 20120277268 - Keshavarz-Shokri; Ali ;   et al.		2012-11-01
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide
App 20120214841 - Hurter; Patricia ;   et al.		2012-08-23
Solid Forms Of Gyrase Inhibitor (r)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-yl]-7-- (tetrahydrofuran-2-yl)-1h-benzimidazol-2-yl]urea
App 20120184564 - Shannon; Dean ;   et al.		2012-07-19
Solid Forms Of Gyrase Inhibitor (r)-1-ethyl-3-[5-[2-(1-hydroxy-methyl-ethyl)pyrimidin-5-yl]-7-(tetrahydro- Furan-2-yl)-1h-benzimidazol-2-yl]urea
App 20120184741 - Shannon; Dean ;   et al.		2012-07-19
Solid Forms Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic Acid
App 20110263654 - Keshavarz-Shokri; Ali ;   et al.		2011-10-27
Solid Forms Of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6- -fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) Cyclopropanecarboxamide
App 20110251253 - Keshavarz-Shokri; Ali ;   et al.		2011-10-13
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide
App 20110230519 - Arekar; Sneha G. ;   et al.		2011-09-22
Solid Forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(- Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide
App 20110123449 - Zhang; Beili ;   et al.		2011-05-26
Solid forms of N-[2,4-BIS(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide
App 20110064811 - Hurter; Patricia ;   et al.		2011-03-17
Solid Forms Of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5- -(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide
App 20100130547 - Zhang; Beili ;   et al.		2010-05-27
Solid Forms Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic Acid
App 20090170905 - Keshavarz-Shokri; Ali ;   et al.		2009-07-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed